These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 12727957)

  • 1. Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.
    Faggiano A; Pivonello R; Melis D; Filippella M; Di Somma C; Petretta M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2003 May; 88(5):2076-80. PubMed ID: 12727957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of circulating levels and renal clearance of natural amino acids in patients with Cushing's disease.
    Faggiano A; Pivonello R; Melis D; Alfieri R; Filippella M; Spagnuolo G; Salvatore F; Lombardi G; Colao A
    J Endocrinol Invest; 2002 Feb; 25(2):142-51. PubMed ID: 11929085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.
    Colao A; Pivonello R; Spiezia S; Faggiano A; Ferone D; Filippella M; Marzullo P; Cerbone G; Siciliani M; Lombardi G
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2664-72. PubMed ID: 10443657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease.
    Faggiano A; Melis D; Alfieri R; De Martino M; Filippella M; Milone F; Lombardi G; Colao A; Pivonello R
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6616-22. PubMed ID: 16174722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidaemia in overweight children and adolescents is associated with an increased risk of kidney stones.
    Kirejczyk JK; Korzeniecka-Kozerska A; Baran M; Porowska H; Porowski T; Wasilewska A
    Acta Paediatr; 2015 Sep; 104(9):e407-13. PubMed ID: 26096629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors.
    Taylor EN; Mount DB; Forman JP; Curhan GC
    Am J Kidney Dis; 2006 May; 47(5):780-9. PubMed ID: 16632016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithogenic risk factors for renal stones in patients with Crohn's disease.
    Buño Soto A; Torres Jiménez R; Olveira A; Fernández-Blanco Herraiz I; Montero García A; Mateos Antón F
    Arch Esp Urol; 2001 Apr; 54(3):282-92. PubMed ID: 11432047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis.
    Sakhaee K; Poindexter JR; Pak CY
    J Urol; 1989 Apr; 141(4):819-21. PubMed ID: 2926871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-h uric acid excretion and the risk of kidney stones.
    Curhan GC; Taylor EN
    Kidney Int; 2008 Feb; 73(4):489-96. PubMed ID: 18059457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic investigation in patients with nephrolithiasis.
    Santos FMD; Peres AK; Mandotti MR; Peres LAB
    Einstein (Sao Paulo); 2017; 15(4):452-456. PubMed ID: 29267427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
    Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G
    J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Response in Patients with Stones, and Low Urinary pH and Hypocitraturia Stratified by Body Mass Index.
    Astroza GM; Neisius A; Tsivian M; Preminger GM; Lipkin ME
    J Urol; 2016 Mar; 195(3):653-7. PubMed ID: 26393903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some aspects of citrate metabolism in renal-stone patients from northeastern Thailand.
    Sriboonlue P; Prasongwatana V; Borvornpadoongkitti S; Suwantrai S
    J Med Assoc Thai; 1996 Nov; 79(11):737-43. PubMed ID: 8997014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.